A new study shows that withaferin A, a steroidal lactone isolated from Withania somnifera, can exert profound metabolic benefits in mice, including body-weight loss, reduced hepatic steatosis and improved glucose control.
This is a preview of subscription content, log in via an institution to check access.
Marina Corral Spence/Nature Publishing Group
References
Tschöp, M.H. et al. Cell Metab. 24, 51–62 (2016).
Lee, J. et al. Nat. Med. 22, 1023–1032 (2016).
Liu, J., Lee, J., Salazar Hernandez, M.A., Mazitschek, R. & Ozcan, U. Cell 161, 999–1011 (2015).
Myers, M.G. Jr. et al. Cell Metab. 15, 150–156 (2012).
Kim, J.E. et al. PLoS One 8, e62068 (2013).
McKenna, M.K. et al. Cancer Biol. Ther. 16, 1088–1098 (2015).
Yang, H. & Dou, Q.P. Curr. Drug Targets 11, 733–744 (2010).
Kleinridders, A. et al. J. Clin. Invest. 123, 4667–4680 (2013).
Zhang, X. et al. Cell 135, 61–73 (2008).
Ma, X. et al. Cell Metab. 22, 695–708 (2015).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
Matthias Tschöp is a scientific advisor to Novo Nordisk, ERX and Bionorica.
Rights and permissions
About this article
Cite this article
Pfluger, P., Tschöp, M. Obesity: will withaferin win the war?. Nat Med 22, 970–971 (2016). https://doi.org/10.1038/nm.4182
Published:
Issue Date:
DOI: https://doi.org/10.1038/nm.4182
- Springer Nature America, Inc.